Y-Intercept (HK)’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.84M | Buy |
164,275
+134,698
| +455% | +$2.33M | 0.07% | 443 |
|
|
2025
Q1 | $647K | Buy |
+29,577
| New | +$647K | 0.04% | 591 |
|
|
2024
Q3 | – | Sell |
-60,522
| Closed | -$2.32M | – | 1284 |
|
|
2024
Q2 | $2.32M | Buy |
+60,522
| New | +$2.32M | 0.13% | 211 |
|
|
2024
Q1 | – | Sell |
-15,008
| Closed | -$898K | – | 1340 |
|
|
2023
Q4 | $898K | Buy |
+15,008
| New | +$898K | 0.08% | 352 |
|
|
2023
Q3 | – | Sell |
-11,595
| Closed | -$1.06M | – | 1038 |
|
|
2023
Q2 | $1.06M | Buy |
11,595
+6,019
| +108% | +$548K | 0.11% | 269 |
|
|
2023
Q1 | $368K | Buy |
+5,576
| New | +$368K | 0.04% | 677 |
|
|
2022
Q2 | – | Sell |
-4,363
| Closed | -$222K | – | 845 |
|
|
2022
Q1 | $222K | Buy |
+4,363
| New | +$222K | 0.05% | 574 |
|